Picton Mahoney Asset Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08M Hold
475,002
0.04% 355
2026
Q1
$5.03M Hold
475,002
0.04% 353
2025
Q4
$4.98M Hold
475,002
0.04% 333
2025
Q3
$4.92M Hold
475,002
0.04% 293
2025
Q2
$4.89M Buy
+475,002
New +$4.83M 0.05% 268

Other funds holding TDAC

Picton Mahoney Asset Management's TDAC Position: Q2 2026 in Review

Picton Mahoney Asset Management held its Translational Development Acquisition Corp (TDAC) position steady in Q2 2026 at 475,002 shares worth $5.08M. The position accounts for 0.04% of the portfolio, ranked #355.

Picton Mahoney Asset Management first reported a position in TDAC in Q2 2025 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Picton Mahoney Asset Management held 475,002 shares of Translational Development Acquisition Corp worth $5.08M as of Q2 2026.
  • Picton Mahoney Asset Management left its Translational Development Acquisition Corp share count unchanged in Q2 2026.
  • Translational Development Acquisition Corp made up 0.04% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #355 holding.
  • Picton Mahoney Asset Management first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 5 quarters since.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.